Related Experiment Video
Updated: Aug 21, 2026

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
[Preventive effect of anterior chamber associated immune deviation on endotoxin-induced uveitis]
Tao Fu1, Pei-Zeng Yang, Xiang-Kun Huang
1Beijing Tongren Eye Center, Tongren Hospital, Capital University of Medical Science, Beijing 100730, China.
Objective:
To determine the effect of anterior chamber associated immune deviation (ACAID) on endotoxin-induced uveitis (EIU) and the possible mechanism.
Methods:
ACAID animal model was induced by injection of 5 microl IRBP (10 microg/microl) into the anterior chamber (AC) of Spar-Dawley (SD) rats. Then 200 microg LPS was injected into hind footpads at different time points after AC inoculation. The animals were randomly divided into 3 groups: positive control (LPS injection only), 3 d group (LPS injection 3 days after IRBP inoculation), 7 d group (LPS injection 7 days after IRBP inoculation). Delayed type hypersensitivity (DTH) was examined to determine the development of ACAID. Then the serum level of IL-10 was evaluated by ELISA, and GATA-3 expression at the different time points after IRBP injection was assayed by reverse transcription polymerase chain reaction (RT-PCR) and Western blot on mRNA and protein level respectively. The ocular inflammation was observed clinically; at the same time, the eye was extirpated and histological examination was performed.
Results:
In control and 3 d groups, significant DTH reaction was induced, but the serum level of IL-10 could not be detected and GATA-3 expression was not increased. While in 7 d group, the DTH reaction could not be induced, and IL-10 and GATA-3 expression increased significantly at both the mRNA and protein levels. The clinical manifestation was significantly alleviated in the 7 d group; Histological examination displayed that the inflammatory cells were significantly reduced in iris/ciliary body, anterior and posterior chambers, vitreous body and retina of the rats in 7 d group.
Conclusion:
The development of ACAID can reduce the ocular inflammation induced by LPS, that is related to the increase of GATA-3 and IL-10 expression.

